Julia is an Analyst on Nasdaq’s Investor Engagement and Global Perception team. She has wide-ranging experience in the biotech and healthcare industry allowing her to better support the investor engagement initiatives of biotech, pharma and medical device clients. Julia advises clients on investor targeting, outreach strategies, peer selection, roadshow planning in addition to other targeting initiatives. Prior to joining Nasdaq, she conducted market research and analyses to support the scaling strategies of start-up health tech companies. She has also focused on interpreting clinical data to improve operational efficiencies and the quality of patient care at an academic hospital network and community mental health program. Julia holds an MBA with a specialization in Health Services Management and a Hon. BSc degree in Life Sciences from McMaster University.